PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Radiation Oncology Journal10.3857/roj.2017.00311201836135-44Impact of radiation dose on concurrent chemoradiotherapy for limited-stage small-cell lung cancerJunhee Park, Min Kyu Kanghttp://e-roj.org/upload/pdf/roj-2017-00311.pdf, http://e-roj.org/journal/view.php?doi=10.3857/roj.2017.00311, http://www.e-roj.org/upload/pdf/roj-2017-00311.pdf
Lung Cancer10.1016/0169-5002(95)90721-11995132229Concurrent chemoradiotherapy followed by surgery for advanced stage III non-small cell lung cancer (NSCLC)https://api.elsevier.com/content/article/PII:0169500295907211?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:0169500295907211?httpAccept=text/plain
Lung Cancer10.1016/s0169-5002(96)80071-71996153396-397Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: A randomized studyhttps://api.elsevier.com/content/article/PII:S0169500296800717?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500296800717?httpAccept=text/plain
Lung Cancer10.1016/0169-5002(95)98958-d1995123311Phase II study of a continuous five-day intravenous infusion of cisplatin and etoposide with concurrent chest radiation therapy in limited stage small cell lung cancerhttps://api.elsevier.com/content/article/PII:016950029598958D?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:016950029598958D?httpAccept=text/plain
BMC Cancer10.1186/1471-2407-5-71200551Concurrent chemoradiotherapy with low dose weekly gemcitabine in stage III non-small cell lung cancerUfuk Abacioglu, Perran F Yumuk, Hale Caglar, Meric Sengoz, Nazim S Turhalhttp://link.springer.com/content/pdf/10.1186/1471-2407-5-71.pdf, http://link.springer.com/article/10.1186/1471-2407-5-71/fulltext.html, http://link.springer.com/content/pdf/10.1186/1471-2407-5-71, https://link.springer.com/content/pdf/10.1186/1471-2407-5-71.pdf
British Journal of Cancer10.1038/s41416-020-01070-62020123S110-17Rationale for concurrent chemoradiotherapy for patients with stage III non-small-cell lung cancerJohn Conibear, http://www.nature.com/articles/s41416-020-01070-6.pdf, http://www.nature.com/articles/s41416-020-01070-6, http://www.nature.com/articles/s41416-020-01070-6.pdf
Clinical Lung Cancer10.3816/clc.2003.n.013200346339-346Radiation Dose Intensification in Limited-Stage Small-Cell Lung CancerKevin S. Roof, Panos Fidias, Thomas J. Lynch, Noah C. Choihttps://api.elsevier.com/content/article/PII:S1525730411703035?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1525730411703035?httpAccept=text/plain
Clinical Lung Cancer10.1016/s1525-7304(11)70614-320002125-26Concurrent Chemoradiotherapy Followed by Consolidation Docetaxel in Stage IIIB Non–Small-Cell Lung Cancer CIG Media Grouphttps://api.elsevier.com/content/article/PII:S1525730411706143?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1525730411706143?httpAccept=text/plain
Lung Cancer10.1016/s0169-5002(19)30249-12019127S85Treatment patterns and outcomes for limited stage small cell lung cancer treated with chemoradiotherapyD. Sim, A. Pascoe, K. Fowerakerhttps://api.elsevier.com/content/article/PII:S0169500219302491?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500219302491?httpAccept=text/plain
Lung Cancer10.1016/s0169-5002(18)30174-02018115S63-S64Service evaluation of stage III non-small cell lung cancer concurrent chemoradiotherapy treatment at Royal Cornwall Hospital Trust, TruroF. Markhttps://api.elsevier.com/content/article/PII:S0169500218301740?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500218301740?httpAccept=text/plain